Technology

EPAM Announces Date for Third Quarter 2024 Earnings Release and Conference Call

Published

5 hours ago

October 8, 2024

NEWTOWN, Pa., Oct. 8, 2024 /PRNewswire/ — EPAM Systems, Inc. (NYSE: EPAM), a leading digital transformation services and product engineering company, will host a conference call at 8:00 a.m. ET, on Thursday, November 7, 2024, to discuss its third quarter 2024 financial results. A news release containing these results will be issued before the call.

The conference call will be live on the EPAM website at https://investors.epam.com.

Please visit the website at least 15 minutes before the call to register for the event. For those who cannot attend the live webcast, a replay will be available in the Investor Relations section of the website.

ABOUT EPAM SYSTEMS
Since 1993, EPAM Systems, Inc. (NYSE: EPAM) has used its software engineering expertise to become a leading global provider of digital engineering, cloud and AI-enabled transformation services, and a leading business and experience consulting partner for global enterprises and ambitious startups. We address our clients’ transformation challenges by fusing EPAM Continuum’s integrated strategy, experience and technology consulting with our 30+ years of engineering execution to speed our clients’ time to market and drive greater value from their innovations and digital investments.

We make GenAI real with our AI LLM orchestration, testing and engineering solutions, EPAM DIAL, EPAM EliteA™ and EPAM AI/RUN™, respectively.

We deliver globally, but engage locally with our expert teams of consultants, architects, designers and engineers, making the future real for our clients, our partners and our people around the world.

We believe the right solutions are the ones that improve people’s lives and fuel competitive advantage for our clients across diverse industries. Our thinking comes to life in the experiences, products and platforms we design and bring to market.

Added to the S&P 500 and the Forbes Global 2000 in 2021 and recognized by Glassdoor and Newsweek as a Top 100 Best Workplace, our multidisciplinary teams serve customers across six continents. We are proud to be among the top 15 companies in Information Technology Services in the Fortune 1000 and to be recognized as a leader in the IDC MarketScapes for Worldwide Experience Build Services, Worldwide Experience Design Services and Worldwide Software Engineering Services as well as a leader in the 2023 Gartner® Magic Quadrant™ for Custom Software Development Services, Worldwide.*

Learn more at www.epam.com and follow us on LinkedIn.

*Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Forward-Looking Statement
This press release includes certain statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Such forward-looking statements are mainly based on our current expectations and estimates of future events and trends, which affect or may affect our business and operations. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. Those future events and trends may relate to, among other things, the closing of the Acquisition, which may not close on the terms or timing anticipated, or at all, the satisfaction or waiver of any conditions to the closing of the Acquisition, the anticipated impacts or benefits of the Acquisition, developments relating to the war in Ukraine and escalation of the war in the surrounding region, political and civil unrest or military action in the geographies where we conduct business and operate, difficult conditions in global capital markets, foreign exchange markets and the broader economy, and the effect that these events may have on client demand and our revenues, operations, access to capital, and profitability. Other factors that could cause actual results to differ materially from those expressed or implied include general economic conditions, the risk factors discussed in our most recent Annual Report on Form 10-K and the factors discussed in our Quarterly Reports on Form 10-Q, particularly under the headings “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” and other filings with the Securities and Exchange Commission. Although we believe that these forward-looking statements are based upon reasonable assumptions, they are subject to several risks and uncertainties and are made based on information currently available to us. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/epam-announces-date-for-third-quarter-2024-earnings-release-and-conference-call-302269139.html

SOURCE EPAM Systems, Inc.

Technology

Armentum Partners Makes Key Senior Hire in Andrew Fineberg to Expand Royalty Capabilities

Published

51 mins ago

October 9, 2024

MENLO PARK, Calif., Oct. 8, 2024 /PRNewswire/ — Armentum Partners, the leading investment bank focused exclusively on raising non-dilutive and structured financings for growth stage healthcare and technology companies, is delighted to announce the addition of senior banker, Andrew Fineberg, as a Managing Director. Andrew joins with a long history of successfully advising academic and not-for-profit institutions around the world on pharmaceutical royalty monetization and corporate clients on the full spectrum of non-dilutive and structured financing options. Andrew, who will be based in New York City, joins Armentum Partners from OrbiMed Advisors, LLC, where he was a Managing Director in the Royalty and Credit Opportunities Fund.

“We are excited to have Andrew join our team. Andrew has a unique and dominant position in the royalty space as one of the most active and well-respected advisors. We believe his experience will allow us to help our academic and corporate clients explore a wider range of non-dilutive and structured financing alternatives,” commented Chris Carthy, Ph.D., Founder and Managing Partner of Armentum Partners. The investment bank now covers all aspects of non-equity financings with a presence in Silicon Valley, New York, Boston, Philadelphia, and Chicago.

On joining, Andrew said “I am thrilled to join Armentum and get back to doing what I enjoy most, delivering royalty solutions to academic institutions and structured financings to companies. I was attracted to Armentum’s market leading position, stellar reputation with investors and clients, and their very experienced senior bankers.”

Andrew has previously held senior roles at SVB Leerink, MTS Health Partners, Torreya Partners, and Cowen & Company. Andrew is a graduate of the Wharton School at the University of Pennsylvania.

About Armentum Partners

Armentum is a full-service, independent financial advisory firm with over 150 years of combined experience in investment banking, commercial banking and lending, venture financing, private and public equity investing, and business development. While Armentum is full-service, its main focus is raising debt and non-dilutive capital raising solutions primarily for technology and healthcare companies. Armentum’s clients benefit from its sector focus and unique backgrounds in the healthcare and scientific fields, including team members with previous careers in engineering and research. Armentum’s managing partners have been working together over the last decade, bringing consistency to each process, and driving its goal of securing the best structure and cost of non-dilutive capital for clients to best meet their strategic growth needs. The firm has remained incredibly active, having raised $16 billion since inception across 350+ transaction, including $2 billion thus far in 2024. Armentum Partners’ employees are fully Registered Representatives of a FINRA member firm.

Media Contact: Kristina Mourlot, kristina@armentumpartners.com, 312-502-0793

View original content:https://www.prnewswire.com/news-releases/armentum-partners-makes-key-senior-hire-in-andrew-fineberg-to-expand-royalty-capabilities-302270766.html

SOURCE Armentum Partners

Technology

Rob Renzi Joins Catalyst Solutions as Chief Growth Officer

Published

52 mins ago

October 9, 2024

Experienced Health Care Leader to Drive Growth

GREENWOOD VILLAGE, Colo., Oct. 8, 2024 /PRNewswire/ — Catalyst Solutions, a leader in innovative solutions to Health Plans, has announced today that Rob Renzi has joined the company as Chief Growth Officer. Renzi brings more than 35 years of leadership experience in sales, business development, and account management in the healthcare industry.

Rachel Spilo, CEO of Catalyst, said, “I’ve known Rob for nearly 20 years. He is exceptionally well-known and well-regarded in our industry. Rob has a proven track record of building and leading sales teams and expanding customer relationships. His extensive knowledge of payer platforms, solutions, and partners will be a tremendous asset to our organization.”

Renzi joins Catalyst from Zelis, a healthcare financial management platform, where he was Senior Vice President of Business Development. Prior to Zelis, he was Senior Vice President and Chief Revenue Officer at Welltok, a SaaS platform for healthcare consumer activation, and was instrumental in Welltok’s sale to Virgin Pulse (now Personify Health). In a 29-year career at TriZetto, one of the industry’s leading claims platforms, he held roles including President of New Business.

Added Renzi, “I love the healthcare technology industry and its commitment to improving people’s lives through innovative solutions, and I have an insatiable passion for being a part of making it better. I’m excited about the opportunity to help Catalyst, its clients, partners, and employees to achieve better health outcomes.”

Added Sas Mukherjee, President of Catalyst, “We are very excited to have Rob lead and accelerate our impressive growth. Rob has a track record of leading earlier waves of growth in adoption of platform and service innovation to health plans. So, it is a testament to the superior value proposition of the solutions from Catalyst that Rob has decided to join us to help Catalyst lead the next wave of innovation and transformation of the industry.”

In his role at Catalyst Solutions, Renzi will lead a team in the pursuit of new clients and securing strategic partnerships to help simplify the complex environment of health benefits and the technology supporting it.

About Catalyst Solutions: Catalyst Solution’s mission is to help health plans improve health outcomes, improve member and provider experience while reducing medical and administrative costs. We are passionate about making positive and measurable improvements on behalf of the clients we serve and the communities in which we live. With 25 years of deep expertise in outsourced health plan outsourcing, IT, and consulting services, Catalyst delivers comprehensive and scalable solutions that meet the unique needs of payers, and we are committed to exceeding customer expectations by providing unmatched service. To learn more, please visit www.catalystsolutions.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rob-renzi-joins-catalyst-solutions-as-chief-growth-officer-302270771.html

SOURCE Catalyst Solutions

Technology

AWAK Transforms into Vivance, Unveiling a New Brand Identity

Published

52 mins ago

October 9, 2024

SINGAPORE, Oct. 9, 2024 /PRNewswire/ — AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding to Vivance. The name, derived from ‘viva’ and ‘advance’, embodies vitality and progress – hallmarks of the company’s commitment to revolutionizing kidney health.

AWAK Technologies was founded with a groundbreaking idea: the development of a wearable dialysis device, Automated Wearable Artificial Kidney (AWAK). As the company continues its mission to transform kidney care, the portfolio has been expanded with products that aim to enhance patient outcomes and quality of life. To reflect this evolution and commitment to innovation, it has rebranded to Vivance – a name that captures its dynamic and forward-thinking approach in managing kidney health.

Suresha Venkataraya, CEO of Vivance, said, “This rebrand reflects how far we’ve come, and where we’re heading. Building on the foundation of our wearable dialysis device, we’ve made significant strides by expanding our portfolio to include cost-effective home modalities and complementary digital offerings. This rebrand reinforces our ultimate mission of treating patients in the comfort of their homes.”

Abel Ang, Chairman of Vivance, added, “We are excited to introduce Vivance to the world. Building on two breakthrough device designations from the FDA, our rebranding accelerates our mission to revolutionize healthcare. This exciting new chapter for the company will see us take patient-centric dialysis from a dream into reality.”

Looking Ahead

As Vivance, the company will continue to refine its brand strategy, product positioning, and approach to market entry, ensuring a strong and strategic alignment with industry needs. The wearable dialysis device is progressing through clinical trials, while additional innovations, such as point-of-care PD fluid generation system, remote monitoring tools and AI prediction models, are in advanced stages of research and development. These products are poised to enter their clinical phases in the near future, reinforcing Vivance’s mission to drive meaningful disruption in the kidney care sector.

Media Contact:

Priyanka Arya
Senior Marketing Manager
+65 6950 5011
priyanka.arya@awak.com

About Vivance

Vivance, formerly AWAK Technologies, is a pioneering, patient-centric medical technology company with a mission to enhance the lives of people with kidney disease and their caregivers by providing solutions to deliver better outcomes and improve their quality of life.

Headquartered in Singapore with offices in Los Angeles, United States and Bengaluru, India, the company is dedicated to the research, development and marketing of novel technologies in kidney care.

Logo – https://mma.prnewswire.com/media/2516325/Vivance_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/awak-transforms-into-vivance-unveiling-a-new-brand-identity-302269606.html